Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMLODIPINE Cause Shock haemorrhagic? 60 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 60 reports of Shock haemorrhagic have been filed in association with AMLODIPINE (Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide). This represents 0.1% of all adverse event reports for AMLODIPINE.

60
Reports of Shock haemorrhagic with AMLODIPINE
0.1%
of all AMLODIPINE reports
33
Deaths
42
Hospitalizations

How Dangerous Is Shock haemorrhagic From AMLODIPINE?

Of the 60 reports, 33 (55.0%) resulted in death, 42 (70.0%) required hospitalization, and 13 (21.7%) were considered life-threatening.

Is Shock haemorrhagic Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMLODIPINE. However, 60 reports have been filed with the FAERS database.

What Other Side Effects Does AMLODIPINE Cause?

Hypotension (6,504) Toxicity to various agents (5,554) Completed suicide (5,267) Drug ineffective (4,091) Dyspnoea (3,907) Dizziness (3,536) Intentional overdose (3,427) Fall (3,215) Fatigue (3,141) Headache (2,907)

What Other Drugs Cause Shock haemorrhagic?

RIVAROXABAN (906) ASPIRIN (830) APIXABAN (476) ENOXAPARIN (473) CLOPIDOGREL BISULFATE (403) DABIGATRAN ETEXILATE (383) WARFARIN (351) HEPARIN (291) TACROLIMUS (241) FUROSEMIDE (204)

Which AMLODIPINE Alternatives Have Lower Shock haemorrhagic Risk?

AMLODIPINE vs AMLODIPINE BESILATE AMLODIPINE vs AMLODIPINE\ATORVASTATIN AMLODIPINE vs AMLODIPINE\BENAZEPRIL AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL

Related Pages

AMLODIPINE Full Profile All Shock haemorrhagic Reports All Drugs Causing Shock haemorrhagic AMLODIPINE Demographics